STUDY PROTOCOL
Year : 2022 | Volume
: 5 | Issue : 4 | Page : 130--136
The protocol for the consensuses of Chinese experts on glioma multidisciplinary team management
The National Glioma MDT Alliance National Center for Neurological Disorders1, Ying Mao2, Tao Jiang3, Guoguang Zhao4
1 National Medical Center for Neurological Diseases, Beijing/Shanghai, China
2 Department of Neurosurgery, National Center for Neurological Disorders, Huashan Hospital, Fudan University; Institute of Medicine, Huashan Hospital, Fudan University, Shanghai, China
3 Beijing Neurosurgical Institute, Capital Medical University; Department of Neurosurgery, National Center for Neurological Disorders, Beijing Tiantan Hospital, Capital Medical University; Center of Brain Tumor, Beijing Institute for Brain Disorders; China National Clinical Research Center for Neurological Diseases, Beijing, China
4 Department of Neurosurgery, National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
Correspondence Address:
The National Glioma MDT Alliance National Center for Neurological Disorders
National Center for Neurological Disorders, No. 12 Wulumuqi Middle Road, Jing'an District, Shanghai
China
Glioma is a highly heterogeneous disease with yet unknown mechanisms. It is imperative to provide individualized and precise treatment based on the multidisciplinary diagnosis and treatment model and the basic principles of evidence-based medicine for these patients. In 2018, the Glioma Society Affiliated to Chinese Medical Doctor Association led the development of the "Chinese Expert Consensus on Multidisciplinary Team (MDT) Management of Glioma," which significantly promoted the application of the MDT approach in China. To standardize the diagnosis and treatment of MDT for glioma in different regions and grades of hospitals, we plan to update the "Chinese Expert Consensus on MDT Management of Glioma" based on the currently available evidence-based medical evidence. This new version will update the standards of surgical procedures, clinical management, and quality control for the implementation of MDT for glioma to provide guidelines and recommendations for clinicians. The Consensus Committee will follow the policies of the Evidence-Based Clinical Practice Guidelines development, form a multidisciplinary expert team, and utilize Evidence-Based Management in line with the Oxford University Center for Evidence-Based Medicine Levels of Evidence and Grades of Recommendation to develop the evidence-based expert consensus on MDT for glioma. The proposal emphasizes the significance, purpose, members of the Consensus Committee, identification of clinical problems, evidence acquisition, evaluation and integration, and recommendation generation.
How to cite this article:
National Center for Neurological Disorders T, Mao Y, Jiang T, Zhao G. The protocol for the consensuses of Chinese experts on glioma multidisciplinary team management.Glioma 2022;5:130-136
|
How to cite this URL:
National Center for Neurological Disorders T, Mao Y, Jiang T, Zhao G. The protocol for the consensuses of Chinese experts on glioma multidisciplinary team management. Glioma [serial online] 2022 [cited 2023 Apr 2 ];5:130-136
Available from: http://www.jglioma.com/article.asp?issn=2589-6113;year=2022;volume=5;issue=4;spage=130;epage=136;aulast=National;type=0 |
|
